56 related articles for article (PubMed ID: 9675105)
1. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids.
Cassarino DS; Swerdlow RH; Parks JK; Parker WD; Bennett JP
Biochem Biophys Res Commun; 1998 Jul; 248(1):168-73. PubMed ID: 9675105
[TBL] [Abstract][Full Text] [Related]
2. Seahorse Xfe 24 Extracellular Flux Analyzer-Based Analysis of Cellular Respiration in Caenorhabditis elegans.
Luz AL; Smith LL; Rooney JP; Meyer JN
Curr Protoc Toxicol; 2015 Nov; 66():25.7.1-25.7.15. PubMed ID: 26523474
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
Shenouda G; Thomson DM
Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
[TBL] [Abstract][Full Text] [Related]
4. Depletion of WFS1 compromises mitochondrial function in hiPSC-derived neuronal models of Wolfram syndrome.
Zatyka M; Rosenstock TR; Sun C; Palhegyi AM; Hughes GW; Lara-Reyna S; Astuti D; di Maio A; Sciauvaud A; Korsgen ME; Stanulovic V; Kocak G; Rak M; Pourtoy-Brasselet S; Winter K; Varga T; Jarrige M; Polvèche H; Correia J; Frickel EM; Hoogenkamp M; Ward DG; Aubry L; Barrett T; Sarkar S
Stem Cell Reports; 2023 May; 18(5):1090-1106. PubMed ID: 37163979
[TBL] [Abstract][Full Text] [Related]
5. High-content high-throughput imaging reveals distinct connections between mitochondrial morphology and functionality for OXPHOS complex I, III, and V inhibitors.
van der Stel W; Yang H; le Dévédec SE; van de Water B; Beltman JB; Danen EHJ
Cell Biol Toxicol; 2023 Apr; 39(2):415-433. PubMed ID: 35505273
[TBL] [Abstract][Full Text] [Related]
6. Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer's Disease.
Wong KY; Roy J; Fung ML; Heng BC; Zhang C; Lim LW
Aging Dis; 2020 Oct; 11(5):1291-1316. PubMed ID: 33014538
[TBL] [Abstract][Full Text] [Related]
7. Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases.
Wang Y; Mishra A; Brinton RD
F1000Res; 2020; 9():. PubMed ID: 32047612
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease.
Pérez MJ; Ponce DP; Aranguiz A; Behrens MI; Quintanilla RA
Redox Biol; 2018 Oct; 19():290-300. PubMed ID: 30199818
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
Swerdlow RH
J Alzheimers Dis; 2018; 62(3):1403-1416. PubMed ID: 29036828
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria, Cybrids, Aging, and Alzheimer's Disease.
Swerdlow RH; Koppel S; Weidling I; Hayley C; Ji Y; Wilkins HM
Prog Mol Biol Transl Sci; 2017; 146():259-302. PubMed ID: 28253988
[TBL] [Abstract][Full Text] [Related]
11. Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex.
Wang Y; Brinton RD
Front Aging Neurosci; 2016; 8():232. PubMed ID: 27757081
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based tumor inhibitor encoding mitochondrial p14(ARF) is highly efficacious to diverse tumors.
Saito K; Iioka H; Kojima C; Ogawa M; Kondo E
Cancer Sci; 2016 Sep; 107(9):1290-301. PubMed ID: 27317619
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.
Wilkins HM; Carl SM; Swerdlow RH
Redox Biol; 2014; 2():619-31. PubMed ID: 25460729
[TBL] [Abstract][Full Text] [Related]
14. Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.
Kawakami M
Brain Sci; 2013 Sep; 3(3):1325-56. PubMed ID: 24961531
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux.
De Marchi E; Bonora M; Giorgi C; Pinton P
Cell Calcium; 2014 Jul; 56(1):1-13. PubMed ID: 24755650
[TBL] [Abstract][Full Text] [Related]
16. Optical imaging of mitochondrial redox state in rodent model of retinitis pigmentosa.
Maleki S; Gopalakrishnan S; Ghanian Z; Sepehr R; Schmitt H; Eells J; Ranji M
J Biomed Opt; 2013 Jan; 18(1):16004. PubMed ID: 23291617
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
Swerdlow RH
Antioxid Redox Signal; 2012 Jun; 16(12):1434-55. PubMed ID: 21902597
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial energetics and therapeutics.
Wallace DC; Fan W; Procaccio V
Annu Rev Pathol; 2010; 5():297-348. PubMed ID: 20078222
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial medicine for neurodegenerative diseases.
Du H; Yan SS
Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile shear stress increased mitochondrial membrane potential: implication of Mn-SOD.
Li R; Beebe T; Cui J; Rouhanizadeh M; Ai L; Wang P; Gundersen M; Takabe W; Hsiai TK
Biochem Biophys Res Commun; 2009 Oct; 388(2):406-12. PubMed ID: 19666009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]